Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ASKG-915 by AskGene Pharma for Transitional Cell Cancer (Urothelial Cell Cancer): Likelihood of Approval
ASKG-915 is under clinical development by AskGene Pharma and currently in Phase I for Transitional Cell Cancer (Urothelial Cell Cancer)....
ASKG-915 by AskGene Pharma for Colorectal Cancer: Likelihood of Approval
ASKG-915 is under clinical development by AskGene Pharma and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...
ASKG-915 by AskGene Pharma for Cervical Cancer: Likelihood of Approval
ASKG-915 is under clinical development by AskGene Pharma and currently in Phase I for Cervical Cancer. According to GlobalData, Phase...
ASKG-915 by AskGene Pharma for Gastric Cancer: Likelihood of Approval
ASKG-915 is under clinical development by AskGene Pharma and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...
ASKG-915 by AskGene Pharma for Hepatocellular Carcinoma: Likelihood of Approval
ASKG-915 is under clinical development by AskGene Pharma and currently in Phase I for Hepatocellular Carcinoma. According to GlobalData, Phase...
ASKG-915 by AskGene Pharma for Renal Cell Carcinoma: Likelihood of Approval
ASKG-915 is under clinical development by AskGene Pharma and currently in Phase I for Renal Cell Carcinoma. According to GlobalData,...
ASKG-915 by AskGene Pharma for Non-Small Cell Lung Cancer: Likelihood of Approval
ASKG-915 is under clinical development by AskGene Pharma and currently in Phase I for Non-Small Cell Lung Cancer. According to...
ASKG-915 by AskGene Pharma for Epithelial Ovarian Cancer: Likelihood of Approval
ASKG-915 is under clinical development by AskGene Pharma and currently in Phase I for Epithelial Ovarian Cancer. According to GlobalData,...
ASKG-915 by AskGene Pharma for Solid Tumor: Likelihood of Approval
ASKG-915 is under clinical development by AskGene Pharma and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
ASKG-915 by AskGene Pharma for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
ASKG-915 is under clinical development by AskGene Pharma and currently in Phase I for Head And Neck Squamous Cell Carcinoma...